The STAR™ Tumor Ablation Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

65 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-31

Study Completion Date

2017-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Registry collecting data on use of The STAR™ Tumor Ablation System.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s)

NCT02225223

Metastatic Lesions in Vertebral Bodies

TERMINATED NA

Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors

NCT02081053

Metastatic Lesions in Vertebral Bodies

TERMINATED NA

Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver

NCT01030757

Liver Cancer

TERMINATED PHASE2

Stereotactic Radiosurgery (SRS) for Spine Metastases

NCT00593320

Spinal Metastases

TERMINATED NA

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

NCT02722395

Primary Liver Cancer Metastatic Liver Cancer From Any Cancer Site

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The STAR Prospective Registry is an observational registry to gather clinical safety and outcome data in patients with painful spinal metastases in the thoracolumbar spine (T1-L5) following targeted radiofrequency ablation (t-RFA) treatment with the STAR™ Tumor Ablation System.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Lesions in Vertebral Bodies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving Targeted Radiofrequency Ablation (t-RFA)

STAR™ Tumor Ablation System

Intervention Type DEVICE

Targeted Radiofrequency ablation of painful metastatic tumor in the vertebral body.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

STAR™ Tumor Ablation System

Targeted Radiofrequency ablation of painful metastatic tumor in the vertebral body.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with painful spinal metastatic lesions in thoracolumbar vertebrae (T1-L5) that will be treated with t-RFA using the STAR™ Tumor Ablation System.
* Have signed informed consent

Exclusion Criteria

* Subjects under 18 years old
* Subjects with heart pacemakers, or other electronic device implants
* Subjects intended for t-RFA in vertebral body levels C1-7

Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No